Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review

por Xing, Biyuan, Guo, Jianfeng, Sheng, Yuhan, Wu, Gang, Zhao, Yingchao
Publicado 2021

Brachytherapy care during the COVID-19 pandemic: Practice statement from a cancer center in Wuhan, China

por Jiang, Yao, Li, Guiling, Xing, Biyuan, Wang, Ye, Liu, Zhao, Zhao, Yingchao
Publicado 2021

Cancer-Associated Fibroblasts Exposed to High-Dose Ionizing Radiation Promote M2 Polarization of Macrophages, Which Induce Radiosensitivity in Cervical Cancer

por Sheng, Yuhan, Zhang, Baofang, Xing, Biyuan, Liu, Zhao, Chang, Yu, Wu, Gang, Zhao, Yingchao
Publicado 2023

Insights into the characteristics of primary radioresistant cervical cancer using single-cell transcriptomics

por Xing, Biyuan, Pu, Congli, Chen, Yunshang, Sheng, Yuhan, Zhang, Baofang, Cui, Jie, Wu, Gang, Zhao, Yingchao
Publicado 2023

PD-1(+) mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

por Li, Jun, Peng, Gang, Zhu, Kuikui, Jie, Xiaohua, Xu, Yingzhuo, Rao, Xinrui, Xu, Yunhong, Chen, Yunshang, Xing, Biyuan, Wu, Gang, Shi, Liangliang
Publicado 2022

Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors

por Xu, Yingzhuo, Wang, Jian, Wang, Xu, Zhou, Xiaoshu, Tang, Jing, Jie, Xiaohua, Yang, Xijie, Rao, Xinrui, Xu, Yunhong, Xing, Biyuan, Li, Zhenyu, Wu, Gang
Publicado 2022

REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis

por Chen, Yunshang, Jie, Xiaohua, Xing, Biyuan, Wu, Zilong, Yang, Xijie, Rao, Xinrui, Xu, Yingzhuo, Zhou, Dong, Dong, Xiaorong, Zhang, Tao, Yang, Kunyu, Li, Zhenyu, Wu, Gang
Publicado 2022

NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer

por Rao, Xinrui, Zhou, Xiaoshu, Wang, Geng, Jie, Xiaohua, Xing, Biyuan, Xu, Yingzhuo, Chen, Yunshang, Li, Jun, Zhu, Kuikui, Wu, Zilong, Wu, Gang, Wu, Chuangyan, Zhou, Rui
Publicado 2022

Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma

por Rao, Xinrui, Xing, Biyuan, Wu, Zilong, Bin, Yawen, Chen, Yunshang, Xu, Yingzhuo, Zhou, Dong, Zhou, Xiaoshu, Wu, Chuangyan, Ye, Wang, Chen, Weibin, Wang, Geng, Zhang, Sheng, Dong, Xiaorong, Meng, Rui, Wu, Gang, Zhou, Rui
Publicado 2023